Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,470 | 49 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $831.77 | 15 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $258.29 | 3 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $250.39 | 3 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $139.53 | 3 | $0 (2021) |
| Amgen Inc. | $125.51 | 2 | $0 (2018) |
| Abbott Laboratories | $124.57 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $115.07 | 1 | $0 (2017) |
| Tandem Diabetes Care, Inc. | $102.54 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $102.00 | 1 | $0 (2017) |
| Phathom Pharmaceuticals, Inc. | $90.84 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $90.84 | 1 | Phathom Pharmaceuticals, Inc. ($90.84) |
| 2022 | $117.43 | 1 | Janssen Pharmaceuticals, Inc ($117.43) |
| 2021 | $198.90 | 11 | Novo Nordisk Inc ($45.58) |
| 2020 | $161.13 | 3 | Teva Pharmaceuticals USA, Inc. ($116.69) |
| 2019 | $403.97 | 8 | Janssen Pharmaceuticals, Inc ($146.15) |
| 2018 | $645.60 | 11 | Janssen Pharmaceuticals, Inc ($131.58) |
| 2017 | $852.38 | 14 | Janssen Pharmaceuticals, Inc ($436.61) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $90.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/29/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $117.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/24/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Cardio-renal | ||||||
| 08/12/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: PRIMARY CARE | ||||||
| 08/09/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: RESPIRATORY | ||||||
| 08/03/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Diabetes | ||||||
| 07/22/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: RESPIRATORY | ||||||
| 07/21/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: UROLOGY | ||||||
| 06/30/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXELIS | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: VACCINE | ||||||
| 06/24/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: NEUROSCIENCE | ||||||
| 05/27/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Diabetes | ||||||
| 05/19/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/13/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Diabetes | ||||||
| 08/19/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: VACCINES | ||||||
| 02/25/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Endocrinology | ||||||
| 02/04/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $116.69 | General |
| Category: Central Nervous System | ||||||
| 12/04/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $102.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/01/2019 | Dexcom, Inc. | DEXCOM CGM (Device) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/31/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/26/2019 | Tandem Diabetes Care, Inc. | t-slim insulin pump (Device) | Food and Beverage | Cash or cash equivalent | $102.54 | General |
| Category: Endocrinology | ||||||
| 06/24/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: Central Nervous System | ||||||
| 05/04/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Central Nervous System | ||||||
| 04/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/18/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 383 | 437 | $58,535 | $17,758 |
| 2022 | 7 | 442 | 506 | $68,792 | $22,703 |
| 2021 | 7 | 464 | 554 | $73,631 | $40,804 |
| 2020 | 10 | 579 | 688 | $90,239 | $43,858 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 138 | $24,840 | $6,396 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 137 | $16,714 | $6,140 | 36.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 76 | 76 | $14,136 | $3,576 | 25.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 33 | $1,320 | $1,035 | 78.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $825.00 | $481.26 | 58.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $700.00 | $129.36 | 18.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 28 | 28 | $0.28 | $0.28 | 100.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 138 | 171 | $20,862 | $8,339 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 141 | $25,380 | $6,612 | 26.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 95 | 95 | $17,670 | $4,875 | 27.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $3,240 | $1,622 | 50.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 41 | 41 | $1,640 | $1,255 | 76.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 28 | 28 | $0.28 | $0.28 | 100.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 12 | 12 | $0.12 | $0.12 | 100.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 133 | 184 | $33,120 | $15,892 | 48.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 105 | 105 | $19,530 | $14,484 | 74.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 111 | 150 | $18,300 | $9,369 | 51.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 52 | 52 | $2,080 | $921.96 | 44.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 12 | 12 | $600.00 | $136.62 | 22.8% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 28 | 28 | $0.28 | $0.28 | 100.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 23 | 23 | $0.23 | $0.23 | 100.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 195 | 259 | $46,620 | $21,156 | 45.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 103 | 103 | $19,158 | $12,460 | 65.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 107 | 151 | $18,422 | $7,257 | 39.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 60 | 60 | $2,400 | $1,057 | 44.1% |
About Dr. Cassandra Constantino, MD
Dr. Cassandra Constantino, MD is a Internal Medicine healthcare provider based in Bristol, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598766537.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cassandra Constantino, MD has received a total of $2,470 in payments from pharmaceutical and medical device companies, with $90.84 received in 2024. These payments were reported across 49 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,470).
As a Medicare-enrolled provider, Constantino has provided services to 1,868 Medicare beneficiaries, totaling 2,185 services with total Medicare billing of $125,122. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Bristol, RI
- Active Since 08/01/2005
- Last Updated 04/17/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1598766537
Products in Payments
- XARELTO (Drug) $623.35
- JARDIANCE (Drug) $234.68
- INVOKANA (Drug) $208.42
- AJOVY (Drug) $133.70
- Prolia (Biological) $125.51
- FreeStyle Libre Pro (Device) $124.57
- AJOVY (Biological) $116.69
- PRALUENT ALIROCUMAB INJECTION (Biological) $115.07
- TOUJEO (Drug) $106.25
- t-slim insulin pump (Device) $102.54
- ENTRESTO (Drug) $102.00
- VOQUEZNA (Drug) $90.84
- Ozempic (Drug) $45.58
- TRULICITY (Drug) $34.46
- SHINGRIX (Biological) $29.96
- NO PRODUCT DISCUSSED (Drug) $29.61
- BREO (Drug) $29.24
- TRELEGY ELLIPTA (Drug) $28.14
- OFEV (Drug) $23.61
- DEXCOM CGM (Device) $21.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bristol
Dr. Bernard Grunstra, Md, MD
Internal Medicine — Payments: $36,895
Charles Villoch, Md, MD
Internal Medicine — Payments: $25,124
Dr. Joseph Foley, M.d, M.D
Internal Medicine — Payments: $21,160
Dr. Nathan Gargus, M.d, M.D
Internal Medicine — Payments: $17,677
Rick Whiles, Md, MD
Internal Medicine — Payments: $17,415
Dr. Donald Quinn, Md, MD
Internal Medicine — Payments: $17,216